Clinical Trial Update: Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents [Phase 4]

View source ↗

Summary

This is a post-marketing Phase 4 study of fluvoxamine maleate for obsessive-compulsive disorder in children and adolescents, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Obsessive Compulsive Disorder | Phase 4 | Status: TERMINATED